AXL and Kaposi's sarcoma: Furthermore, Liu et al. [177] described the use of a monoclonal antibody (MAb173), that not only induces Axl degradation in vitro and leads to inhibition of Kaposi sarcoma cell invasion, but also reduces tumor growth, increases tumor cell apoptosis, decreasing the Axl level in in vivo xenograft studies [177].